Chinese Firm Sinopharm Reports Promising Results for COVID-19 Vaccine Trials

The anti-Covid vaccine from the Chinese pharmaceutical group Sinopharm, chosen by Morocco, is about to be completed thanks to the results of clinical trials.
In a press release, the pharmaceutical group indicated on Wednesday, November 11 that the data obtained from the large-scale clinical trials were "better than expected".
According to Reuters, the 3rd phase of clinical trials has been launched for the two vaccine candidates by China National Biotec Group (CNBG), which is a Sinopharm unit. These trials have been conducted in the United Arab Emirates, Bahrain and Egypt on more than 50,000 volunteers from these countries.
Pending the completion of the trials, the group should provide more details on the data from the trials of one of the two group’s vaccines.
Related Articles
-
Casablanca Beach Town Bans Jet Skis After Tragic Accident Injures 4-Year-Old
23 July 2025
-
UK Accused of ’Justice Outsourcing’ in Securitas Heist Case: MMA Fighter’s Conviction Sparks Controversy
23 July 2025
-
Morocco’s Ambitious 105km Guercif-Nador Motorway: Reshaping the Oriental Region’s Future
22 July 2025
-
Gold Price Drop Sparks Wedding Season Boom for Moroccan Jewelers
22 July 2025
-
Taxi Fare Scandal: Tangier Consumers Fight Back Against Illegal Price Hikes
22 July 2025